In Vivo Imaging of Molecularly Targeted Phage
Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-12-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558606801065 |
id |
doaj-49853ab331d046f88f82a00a3f8f767a |
---|---|
record_format |
Article |
spelling |
doaj-49853ab331d046f88f82a00a3f8f767a2020-11-24T22:24:05ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022006-12-018121011101810.1593/neo.06610In Vivo Imaging of Molecularly Targeted PhageKimberly A. KellyPeter WatermanRalph Weissleder Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of ~ 300 phage/mm3 tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents. http://www.sciencedirect.com/science/article/pii/S1476558606801065Phage displayscreeningdrug discoverymolecular imagingsystems biology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kimberly A. Kelly Peter Waterman Ralph Weissleder |
spellingShingle |
Kimberly A. Kelly Peter Waterman Ralph Weissleder In Vivo Imaging of Molecularly Targeted Phage Neoplasia: An International Journal for Oncology Research Phage display screening drug discovery molecular imaging systems biology |
author_facet |
Kimberly A. Kelly Peter Waterman Ralph Weissleder |
author_sort |
Kimberly A. Kelly |
title |
In Vivo Imaging of Molecularly Targeted Phage |
title_short |
In Vivo Imaging of Molecularly Targeted Phage |
title_full |
In Vivo Imaging of Molecularly Targeted Phage |
title_fullStr |
In Vivo Imaging of Molecularly Targeted Phage |
title_full_unstemmed |
In Vivo Imaging of Molecularly Targeted Phage |
title_sort |
in vivo imaging of molecularly targeted phage |
publisher |
Elsevier |
series |
Neoplasia: An International Journal for Oncology Research |
issn |
1476-5586 1522-8002 |
publishDate |
2006-12-01 |
description |
Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of ~ 300 phage/mm3 tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents.
|
topic |
Phage display screening drug discovery molecular imaging systems biology |
url |
http://www.sciencedirect.com/science/article/pii/S1476558606801065 |
work_keys_str_mv |
AT kimberlyakelly invivoimagingofmolecularlytargetedphage AT peterwaterman invivoimagingofmolecularlytargetedphage AT ralphweissleder invivoimagingofmolecularlytargetedphage |
_version_ |
1725762304503447552 |